✦ LIBER ✦

Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: A double-blind placebo-controlled study

✍ Scribed by B. Omer; S. Krebs; H. Omer; T.O. Noor

Book ID: 113848124
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 238 KB
Volume: 14
Category: Article
ISSN: 0944-7113
DOI: 10.1016/j.phymed.2007.01.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steroid-sparing effects of methotrexate

Steroid-sparing effects of methotrexate in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled trial

✍ Fortin, Paul R. ;Abrahamowicz, Michal ;Ferland, Diane ;Lacaille, Diane ;Smith, C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

Clinical trial: vitamin D3 treatment in

Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double-blind placebo-controlled study

✍ S. P. Jørgensen; J. Agnholt; H. Glerup; S. Lyhne; G. E. Villadsen; C. L. Hvas; L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Quality of life in patients with Crohn's

Quality of life in patients with Crohn's disease in A double blind placebo controlled nutritional intervention study

✍ Geerling, B.J.; Russel, M.G.V.M.; Stockbrügger, R.W.; Brummer, R-J-M. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Restoration of muscle strength after nut

Restoration of muscle strength after nutritional supplementation in patients with Crohn's disease in a double blind placebo controlled study

✍ Geerling, B.J.; van Deursen, C.; Stockbrügger, R.W.; Brummer, R-J.M. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Fontolizumab in moderate to severe Crohn

Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study

✍ Walter Reinisch; Williem de Villiers; László Bene; László Simon; István Rácz; Se 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

## Background: The safety and efficacy of fontolizumab, a humanized anti-interferon gamma antibody, was investigated in patients with Crohn's disease (CD). Elevated gut mucosal levels of interferon gamma, a key cytokine involved in the inflammatory process of CD, are associated with disease symptom

Double-blinded, randomized, placebo-cont

Double-blinded, randomized, placebo-controlled trial of the remission inducing and steroid sparing properties of two schedules of ISIS 2302 (ICAM-1 antisense) in active, steroid-dependent crohn's disease

✍ Yacyshyn, Bruce R.; Chey, W.; Goff, J.; Salzberg, B.; Buchman, A.; Baerg, R.; An 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 175 KB